BL 323 (Relcof IR guaifenesin 380 mg / phenylephrine hydrochloride 10 mg)
Generic Name: guaifenesin/phenylephrine
Pill imprint BL 323 has been identified as Relcof IR guaifenesin 380 mg / phenylephrine hydrochloride 10 mg.
Relcof IR is used in the treatment of cough and nasal congestion; sinus symptoms and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Relcof IR guaifenesin 380 mg / phenylephrine hydrochloride 10 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- BL 323
- guaifenesin 380 mg / phenylephrine hydrochloride 10 mg
- Elliptical / Oval
- Rx and/or OTC
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Burel Pharmaceuticals, Inc.
More about Relcof IR (guaifenesin / phenylephrine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: upper respiratory combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.